Ozempic is an injectable GLP-1 receptor agonist containing the active ingredient semaglutide, prescribed for type 2 diabetes and, increasingly, for weight loss under the brand name Wegovy
Delivered under clinician guidance, it focuses on supporting how the body maintains energy levels and physiological balance over time
This test looks back 6 months in your nutritional history to measure how well your body has utilized 33 vitamins, minerals, amino/fatty acids and antioxidants
This variability in dosing may offer greater precision in tailoring treatment regimens to meet specific weight loss goals
Drug compounding is a well-established practice
Eligibility for Prescription Weight Loss Treatment Weight loss medications approved by the FDA can typically be prescribed for individuals with a BMI of 30 or above, or a BMI of 27 with accompanying health issues like type 2 diabetes, elevated blood pressure, or high cholesterol